• Je něco špatně v tomto záznamu ?

Tissue-specific TCF4 triplet repeat instability revealed by optical genome mapping

C. Zarouchlioti, S. Efthymiou, S. Facchini, N. Dominik, N. Bhattacharyya, S. Liu, MA. Costa, A. Szabo, AN. Sadan, AS. Jun, E. Bugiardini, H. Houlden, A. Cortese, P. Skalicka, L. Dudakova, K. Muthusamy, ME. Cheetham, AJ. Hardcastle, P. Liskova,...

. 2024 ; 108 (-) : 105328. [pub] 20240914

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25004004

BACKGROUND: Fuchs endothelial corneal dystrophy (FECD) is the most common repeat-mediated disease in humans. It exclusively affects corneal endothelial cells (CECs), with ≤81% of cases associated with an intronic TCF4 triplet repeat (CTG18.1). Here, we utilise optical genome mapping (OGM) to investigate CTG18.1 tissue-specific instability to gain mechanistic insights. METHODS: We applied OGM to a diverse range of genomic DNAs (gDNAs) from patients with FECD and controls (n = 43); CECs, leukocytes and fibroblasts. A bioinformatics pipeline was developed to robustly interrogate CTG18.1-spanning DNA molecules. All results were compared with conventional polymerase chain reaction-based fragment analysis. FINDINGS: Analysis of bio-samples revealed that expanded CTG18.1 alleles behave dynamically, regardless of cell-type origin. However, clusters of CTG18.1 molecules, encompassing ∼1800-11,900 repeats, were exclusively detected in diseased CECs from expansion-positive cases. Additionally, both progenitor allele size and age were found to influence the level of leukocyte-specific CTG18.1 instability. INTERPRETATION: OGM is a powerful tool for analysing somatic instability of repeat loci and reveals here the extreme levels of CTG18.1 instability occurring within diseased CECs underpinning FECD pathophysiology, opening up new therapeutic avenues for FECD. Furthermore, these findings highlight the broader translational utility of FECD as a model for developing therapeutic strategies for rarer diseases similarly attributed to somatically unstable repeats. FUNDING: UK Research and Innovation, Moorfields Eye Charity, Fight for Sight, Medical Research Council, NIHR BRC at Moorfields Eye Hospital and UCL Institute of Ophthalmology, Grantová Agentura České Republiky, Univerzita Karlova v Praze, the National Brain Appeal's Innovation Fund and Rosetrees Trust.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25004004
003      
CZ-PrNML
005      
20250206105032.0
007      
ta
008      
250121e20240914ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ebiom.2024.105328 $2 doi
035    __
$a (PubMed)39278108
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Zarouchlioti, Christina $u UCL Institute of Ophthalmology, London, UK
245    10
$a Tissue-specific TCF4 triplet repeat instability revealed by optical genome mapping / $c C. Zarouchlioti, S. Efthymiou, S. Facchini, N. Dominik, N. Bhattacharyya, S. Liu, MA. Costa, A. Szabo, AN. Sadan, AS. Jun, E. Bugiardini, H. Houlden, A. Cortese, P. Skalicka, L. Dudakova, K. Muthusamy, ME. Cheetham, AJ. Hardcastle, P. Liskova, SJ. Tuft, AE. Davidson
520    9_
$a BACKGROUND: Fuchs endothelial corneal dystrophy (FECD) is the most common repeat-mediated disease in humans. It exclusively affects corneal endothelial cells (CECs), with ≤81% of cases associated with an intronic TCF4 triplet repeat (CTG18.1). Here, we utilise optical genome mapping (OGM) to investigate CTG18.1 tissue-specific instability to gain mechanistic insights. METHODS: We applied OGM to a diverse range of genomic DNAs (gDNAs) from patients with FECD and controls (n = 43); CECs, leukocytes and fibroblasts. A bioinformatics pipeline was developed to robustly interrogate CTG18.1-spanning DNA molecules. All results were compared with conventional polymerase chain reaction-based fragment analysis. FINDINGS: Analysis of bio-samples revealed that expanded CTG18.1 alleles behave dynamically, regardless of cell-type origin. However, clusters of CTG18.1 molecules, encompassing ∼1800-11,900 repeats, were exclusively detected in diseased CECs from expansion-positive cases. Additionally, both progenitor allele size and age were found to influence the level of leukocyte-specific CTG18.1 instability. INTERPRETATION: OGM is a powerful tool for analysing somatic instability of repeat loci and reveals here the extreme levels of CTG18.1 instability occurring within diseased CECs underpinning FECD pathophysiology, opening up new therapeutic avenues for FECD. Furthermore, these findings highlight the broader translational utility of FECD as a model for developing therapeutic strategies for rarer diseases similarly attributed to somatically unstable repeats. FUNDING: UK Research and Innovation, Moorfields Eye Charity, Fight for Sight, Medical Research Council, NIHR BRC at Moorfields Eye Hospital and UCL Institute of Ophthalmology, Grantová Agentura České Republiky, Univerzita Karlova v Praze, the National Brain Appeal's Innovation Fund and Rosetrees Trust.
650    _2
$a lidé $7 D006801
650    12
$a transkripční faktor 4 $x genetika $x metabolismus $7 D000073940
650    12
$a Fuchsova endoteliální dystrofie $x genetika $x patologie $7 D005642
650    _2
$a mapování chromozomů $7 D002874
650    _2
$a alely $7 D000483
650    _2
$a orgánová specificita $x genetika $7 D009928
650    _2
$a expanze trinukleotidových repetic $7 D019680
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nestabilita genomu $7 D042822
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a trinukleotidové repetice $x genetika $7 D018911
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři $7 D000368
655    _2
$a časopisecké články $7 D016428
700    1_
$a Efthymiou, Stephanie $u UCL Queen Square Institute of Neurology, Department of Neuromuscular Diseases, London, UK
700    1_
$a Facchini, Stefano $u UCL Queen Square Institute of Neurology, Department of Neuromuscular Diseases, London, UK
700    1_
$a Dominik, Natalia $u UCL Queen Square Institute of Neurology, Department of Neuromuscular Diseases, London, UK
700    1_
$a Bhattacharyya, Nihar $u UCL Institute of Ophthalmology, London, UK
700    1_
$a Liu, Siyin $u UCL Institute of Ophthalmology, London, UK; Moorfields Eye Hospital, London, UK
700    1_
$a Costa, Marcos Abreu $u UCL Institute of Ophthalmology, London, UK
700    1_
$a Szabo, Anita $u UCL Institute of Ophthalmology, London, UK
700    1_
$a Sadan, Amanda N $u UCL Institute of Ophthalmology, London, UK
700    1_
$a Jun, Albert S $u Cornea, Cataract, and External Disease Division, Wilmer Eye Institute, Johns Hopkins Medicine, Baltimore, USA
700    1_
$a Bugiardini, Enrico $u UCL Queen Square Institute of Neurology, Department of Neuromuscular Diseases, London, UK
700    1_
$a Houlden, Henry $u UCL Queen Square Institute of Neurology, Department of Neuromuscular Diseases, London, UK
700    1_
$a Cortese, Andrea $u UCL Queen Square Institute of Neurology, Department of Neuromuscular Diseases, London, UK
700    1_
$a Skalicka, Pavlina $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Dudakova, Lubica $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Muthusamy, Kirithika $u Moorfields Eye Hospital, London, UK
700    1_
$a Cheetham, Michael E $u UCL Institute of Ophthalmology, London, UK
700    1_
$a Hardcastle, Alison J $u UCL Institute of Ophthalmology, London, UK
700    1_
$a Liskova, Petra $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Tuft, Stephen J $u UCL Institute of Ophthalmology, London, UK; Moorfields Eye Hospital, London, UK
700    1_
$a Davidson, Alice E $u UCL Institute of Ophthalmology, London, UK; Moorfields Eye Hospital, London, UK. Electronic address: alice.davidson@ucl.ac.uk
773    0_
$w MED00190061 $t EBioMedicine $x 2352-3964 $g Roč. 108 (20240914), s. 105328
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39278108 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206105027 $b ABA008
999    __
$a ok $b bmc $g 2263631 $s 1240011
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 108 $c - $d 105328 $e 20240914 $i 2352-3964 $m EBioMedicine $n EBioMedicine $x MED00190061
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace